Related Experiment Videos
Gene therapy for chronic granulomatous disease
W Scott Goebel1, Mary C Dinauer
1Herman B Wells Center for Pediatric Research and Department of Pediatrics (Hematology/Oncology), James Whitcomb Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.
Acta Haematologica
|October 30, 2003
Summary
Gene therapy offers a promising approach for correcting chronic granulomatous disease (CGD), a leukocyte disorder. Research focuses on restoring NADPH oxidase function in hematopoietic stem cells for potential cures.
Area of Science:
- Immunology
- Molecular Biology
- Genetic Medicine
Background:
- Chronic granulomatous disease (CGD) is an inherited phagocyte disorder caused by mutations in NADPH oxidase genes.
- Defective reactive oxygen intermediate production leads to recurrent infections and inflammation in CGD patients.
- Allogeneic bone marrow transplantation offers a cure but faces limitations due to toxicity and donor availability.
Purpose of the Study:
- To explore somatic gene therapy as a treatment for CGD by targeting hematopoietic stem cells.
- To evaluate the potential of gene transfer technology for correcting leukocyte dysfunction in CGD.
Main Methods:
- Gene transfer studies in human CGD marrow and cell lines in vitro.
- Development and preclinical testing of CGD mouse models using gene disruption and retroviral vectors.
- Analysis of NADPH oxidase activity and neutrophil function in treated animal models.
Main Results:
- Successful reconstitution of NADPH oxidase activity demonstrated in vitro.
- Murine studies showed functional neutrophil recovery and enhanced pathogen resistance in gene-corrected CGD models.
- Early-phase human clinical trials have not yet achieved sustained, clinically significant levels of corrected neutrophils.
Conclusions:
- Somatic gene therapy is a promising avenue for CGD treatment, with successful preclinical results in animal models.
- Further research is needed to enhance gene transfer efficiency and stem cell engraftment in humans.
- Ongoing efforts aim to improve the clinical efficacy of gene therapy for inherited leukocyte disorders.